Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.440
-0.150 (-5.79%)
At close: Apr 16, 2026, 4:00 PM EDT
2.430
-0.010 (-0.41%)
After-hours: Apr 16, 2026, 5:59 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $438.52 million as of April 16, 2026. Its market cap has increased by 970.68% in one year.
Market Cap
438.52M
Enterprise Value
372.16M
1-Year Change
970.68%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $438.52M, a decrease of -58.27%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 465.48M | 435.90% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 426.35M |
| Vanda Pharmaceuticals | 423.21M |
| Altimmune | 420.24M |
| Enanta Pharmaceuticals | 414.11M |
| Climb Bio | 412.24M |
| Benitec Biopharma | 411.06M |
| YD Bio | 403.64M |
| Rocket Pharmaceuticals | 397.21M |